Wang Lei, Wang Xueying, Guo Erliang, Mao Xionghui, Miao Susheng
Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China.
Front Oncol. 2022 Jul 22;12:939089. doi: 10.3389/fonc.2022.939089. eCollection 2022.
The main role of platelets is to control bleeding and repair vascular damage thrombosis. They have also been implicated to promote tumor metastasis through platelet-tumor cell interactions. Platelet-tumor cell interactions promote tumor cell survival and dissemination in blood circulation. Tumor cells are known to induce platelet activation and alter platelet RNA profiles. Liquid biopsies based on tumor-educated platelet biomarkers can detect tumors and correlate with prognosis, personalized therapy, treatment monitoring, and recurrence prediction. Platelet-based strategies for cancer prevention and tumor-targeted therapy include developing drugs that target platelet receptors, interfere with the release of platelet particles, inhibit platelet-specific enzymes, and utilize platelet-derived "nano-platelets" as a targeted drug delivery platform for tumor therapy. This review elaborates on platelet-tumor cell interactions and the molecular mechanisms and discusses future research directions for platelet-based liquid biopsy techniques and platelet-targeted anti-tumor strategies.
血小板的主要作用是控制出血和修复血管损伤(血栓形成)。它们还被认为通过血小板 - 肿瘤细胞相互作用促进肿瘤转移。血小板 - 肿瘤细胞相互作用促进肿瘤细胞在血液循环中的存活和扩散。已知肿瘤细胞可诱导血小板活化并改变血小板RNA谱。基于肿瘤驯化血小板生物标志物的液体活检可以检测肿瘤,并与预后、个性化治疗、治疗监测和复发预测相关联。基于血小板的癌症预防和肿瘤靶向治疗策略包括开发靶向血小板受体的药物、干扰血小板颗粒的释放、抑制血小板特异性酶,以及利用血小板衍生的“纳米血小板”作为肿瘤治疗的靶向药物递送平台。本文综述详细阐述了血小板 - 肿瘤细胞相互作用及其分子机制,并讨论了基于血小板的液体活检技术和血小板靶向抗肿瘤策略的未来研究方向。